Regulation
FDA grants breakthrough status to Capitan Orthopedics’ SupraSpacer implant
The FDA granted breakthrough device designation to Capitan Orthopedics for its SupraSpacer implant, designed to treat irreparable rotator cuff tears. Breakthrough status accelerates the review pathway for devices that address unmet clinical needs and show potential advantages over existing alternatives.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network